Amlodipine/valsartan, sold under the brand name Exforge among others, is a blood pressure lowering combination drug. It contains amlodipine, as the besilate, a dihydropyridine-type calcium channel blocker, and valsartan, an angiotensin II receptor antagonist.[3] This combination is usually well tolerated and effective for the reduction of blood pressure.[4]
Combination of | |
---|---|
Amlodipine | Calcium channel blocker |
Valsartan | Angiotensin II receptor antagonist |
Clinical data | |
Trade names | Exforge |
AHFS/Drugs.com | Professional Drug Facts |
License data | |
Pregnancy category |
|
Routes of administration | By mouth |
ATC code |
|
Legal status | |
Legal status | |
Identifiers | |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
KEGG |
|
CompTox Dashboard (EPA) |
|
(verify) |
The combination was approved for medical use in the United States in June 2007.[5]
The combination is also available with included hydrochlorothiazide (Exforge HCT), for people who need a three-drug regimen to manage their blood pressure.[6][7] It was approved for medical use in the United States in April 2009.[8]